SWOT Analysis for Brooks Laboratories Ltd. - Threats

Add SWOT widget to your site/app

Rising Net Cash Flow and Cash from Operating activity

Expensive Performers (DVM)

PEG lower than Industry PEG

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding

Promoter holding decreased by more than -2% QoQ

Negative profit growth, promoters decreasing shareholding QoQ

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Decline in Net Profit (QoQ)

Declining profits every quarter for the past 2 quarters

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Rising Delivery Percentage Compared to Prev Day

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Significant Change in Promoter Shareholding - Latest Quarter

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks